www.gregordiagnostics.com Open in urlscan Pro
35.156.117.131  Public Scan

Form analysis
0 forms found in the DOM

Text Content

HomeProblemTeamNewsCareers
HomeProblemTeamNewsCareers
HomeProblemTeamNewsCareers
HomeProblemTeamNewsCareers
HomeProblemTeamNewsCareers
   Home
   Problem
   Team
   News
   Careers
 * 
 * 



 * BETTER SCREENING FOR PROSTATE CANCER
   
   IMPACT LIFE • DO WHAT’S RIGHT • INNOVATE TOGETHER • BUILD COMMUNITY
   
   LEARN MORE

 * SCREENING IS DECLINING
   
   BECAUSE THE PSA TEST IS NO LONGER RECOMMENDED, SCREENING RATES OF MEN IN THE
   UNITED STATES HAVE DECLINED. LOWER SCREENING REDUCES THE OVERDIAGNOSIS AND
   OVERTREATMENT OF PROSTATE CANCER AS INTENDED BY THE RECOMMENDATION. HOWEVER,
   BY SCREENING LESS MEN FOR PROSTATE CANCER, THE AGGRESSIVE CANCERS WILL ALSO
   BE MISSED. THIS WILL TRIGGER MORE DEATHS THAT COULD HAVE BEEN AVOIDED.
   
   LET'S NOT ABANDON SCREENING; LET'S BUILD A BETTER SCREENING TEST.
   
   USPSTF Recommendation
   
   THE PROBLEM
   
   PROSTATE CANCER IS THE SECOND DEADLIEST CANCER FOR AMERICAN MEN. MORE THAN
   191,930 MEN WILL BE DIAGNOSED IN 2020 AND 33,330 WILL DIE FROM PROSTATE
   CANCER. SIMULTANEOUSLY, IT IS OVERDIAGNOSED AND OVERTREATED IN MEN WITH
   INDOLENT (LESS AGGRESSIVE) PROSTATE CANCER. THIS LEADS TO UNNECESSARY
   TREATMENTS SUCH AS PROSTATECTOMY AND RADIATION THERAPY.
   
   ACS Prostate Cancer Facts and Figures
   
   PSA: AN IMPERFECT SCREENING TOOL
   
   PROSTATE SPECIFIC ANTIGEN OR PSA IS CURRENTLY THE STANDARD TEST USED FOR
   PROSTATE CANCER SCREENING. HOWEVER, IT HAS SEVERAL SHORTCOMINGS, INCLUDING:
   
    * PSA CAN BE ELEVATED FOR REASONS OTHER THAN PROSTATE CANCER.
   
    * PSA AND ITS VARIANTS MISS A LARGE PORTION OF AGGRESSIVE PROSTATE CANCERS.
   
    * PSA CAN’T DISTINGUISH BETWEEN INDOLENT AND AGGRESSIVE PROSTATE CANCERS.
      LEADING MANY PATIENTS TO UNDERGO UNNECESSARY TREATMENTS.
   
   Read the Article
   
   SCREENING IS DECLINING
   
   BECAUSE THE PSA TEST IS NO LONGER RECOMMENDED, SCREENING RATES OF MEN IN THE
   UNITED STATES HAVE DECLINED. LOWER SCREENING REDUCES THE OVERDIAGNOSIS AND
   OVERTREATMENT OF PROSTATE CANCER AS INTENDED BY THE RECOMMENDATION. HOWEVER,
   BY SCREENING LESS MEN FOR PROSTATE CANCER, THE AGGRESSIVE CANCERS WILL ALSO
   BE MISSED. THIS WILL TRIGGER MORE DEATHS THAT COULD HAVE BEEN AVOIDED.
   
   LET'S NOT ABANDON SCREENING; LET'S BUILD A BETTER SCREENING TEST.
   
   USPSTF Recommendation
   
   THE PROBLEM
   
   PROSTATE CANCER IS THE SECOND DEADLIEST CANCER FOR AMERICAN MEN. MORE THAN
   191,930 MEN WILL BE DIAGNOSED IN 2020 AND 33,330 WILL DIE FROM PROSTATE
   CANCER. SIMULTANEOUSLY, IT IS OVERDIAGNOSED AND OVERTREATED IN MEN WITH
   INDOLENT (LESS AGGRESSIVE) PROSTATE CANCER. THIS LEADS TO UNNECESSARY
   TREATMENTS SUCH AS PROSTATECTOMY AND RADIATION THERAPY.
   
   ACS Prostate Cancer Facts and Figures
   
   
   

 * OUR MISSION
   
   ● IMPACT LIFE ●
   
   WE STRIVE TO MAKE AN IMPACT ON LIVES THAT CAN BE SAVED, TO HAVE A POSITIVE
   IMPACT ON THE LIVES OF OUR PATIENTS, PHYSICIANS, PARTNERS AND EMPLOYEES.
   
   ● DO WHAT'S RIGHT ●
   
   WE WILL CONTINUE TO ALWAYS DO WHATS RIGHT.
    
   
   ● INNOVATE TOGETHER ●
   WE ARE BUILDING A BETTER TEST TO SCREEN FOR AND DETERMINE THE AGGRESSIVENESS
   OF PROSTATE CANCER.
   
    
   
   ● BUILD COMMUNITY ●
   
   ONLY WITH THE COMMUNITY AROUND US CAN WE BRING THIS SCREENING TEST TO THE
   FOREFRONT AND HELP MORE MEN GET TESTED
   
   
    
   
   READ OUR UPDATES
 * 

 * CONTACT US
   
   WE WANT TO HEAR FROM YOU TODAY!
   
   Name
   Email
   Message
   
   Submit
   Comment
   








All Posts
×



Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume
you accept the use of cookies.
Accept
Learn More